Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet

International Journal of Obesity

Volumn 37, Issue 8, 2013, Pages 1064-1070

  Brozinick, J T ^a   Hawkins, E ^a   Hoang Bui, H ^a   Kuo, M S ^a   Tan, B ^a   Kievit, P ^b   Grove, K ^b  

^a ELI LILLY AND COMPANY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ceramide; insulin resistance; rhesus monkey

Indexed keywords

BIOLOGICAL MARKER; CERAMIDE; CHOLESTEROL; DEOXYSPHINGANINE; GANGLIOSIDE GM3; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SERINE; SERINE PALMITOYLTRANSFERASE; SPHINGANINE; SPHINGOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; ENZYME SPECIFICITY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID DIET; LIPOGENESIS; LIPOLYSIS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; RHESUS MONKEY; WESTERN DIET;

ANIMALIA; MACACA MULATTA; PRIMATES; RODENTIA;

ANIMALS; BIOLOGICAL MARKERS; CERAMIDES; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FRUCTOSE; INSULIN RESISTANCE; MACACA MULATTA; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SERINE C-PALMITOYLTRANSFERASE; SPHINGOLIPIDS; VALINE;

EID: 84881163357     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.191     Document Type: Article

References (58)

1. Bloomgarden ZT. World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease. Diabetes Care 2011; 34: e140-e145.
2. Summers SA. Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol 2010; 21: 128-135.
3. Yang G, Badeanlou L, Bielawski J, Roberts AJ, Hannun YA, Samad F. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2009; 297: E211-E224.
4. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165.
5. Summers SA, Nelson DH. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 2005; 54: 591-602.
6. Hornemann T, Penno A, Rutti MF, Ernst D, Kivrak-Pfiffner F, Rohrer L et al. The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J Biol Chem 2009; 284: 26322-26330.
7. Hornemann T, Richard S, Rutti MF, Wei Y, von Eckardstein A. Cloning and initial characterization of a new subunit for mammalian serine- palmitoyltransferase. J Biol Chem 2006; 281: 37275-37281.
8. Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 2003; 1632: 16-30.
9. Hannun YA, Obeid LM. Many ceramides. J Biol Chem 2011; 286: 27855-27862.
10. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010; 327: 46-50.
11. Lingwood D, Kaiser H-J, Levental I, Simons K. Lipid rafts as functional heterogeneity in cell membranes. Biochem Soc Trans 2009; 037: 955-960.
12. van Blitterswijk WJ, van der Luit AH, Veldman RJ, Verheij M, Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 2003; 369(Pt 2): 199-211.
13. Mitsutake S, Zama K, Yokota H, Yoshida T, Tanaka M, Mitsui M et al. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes. J Biol Chem 2011; 286: 28544-28555.
14. Stratford S, Hoehn KL, Liu F, Summers SA. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 2004; 279: 36608-36615.
15. Fox TE, Houck KL, O'Neill SM, Nagarajan M, Stover TC, Pomianowski PT et al. Ceramide recruits and activates protein kinase C z (PKCz) within structured membrane microdomains. J Biol Chem 2007; 282: 12450-12457.
16. Gao X, Lowry PR, Zhou X, Depry C, Wei Z, Wong GW et al. PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc Natl Acad Sci USA 2011; 108: 14509-14514.
17. Goñ i FM, Alonso A. Effects of ceramide and other simple sphingolipids on membrane lateral structure. Biochim Biophys Acta 2009; 1788: 169-177.
18. Holland WL, Brozinick JT, Wang L-P, Hawkins ED, Sargent KM, Liu Y et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesityinduced insulin resistance. Cell Metab 2007; 5: 167-179.
19. Kasumov T, Huang H, Solomon TPJ, Haus J, Kirwan JP. Exercise induced improvements in insulin sensitivity are related to changes in muscle ceramides and sphingosine 1-phosphate in obesity and diabetes. Diabetes 2011; 60(Suppl 1): A39.
20. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, DeFronzo RA et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009; 58: 337-343.
21. de Mello V, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Seppänen-Laakso T et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 2009; 52: 2612-2615.
22. Shui G, Stebbins JW, Lam BD, Cheong WF, Lam SM, Gregoire F et al. Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys? PLoS One, 2011; 6(5): e19731.
23. Huang H, Kasumov T, Gatmaitan P, Heneghan HM, Kashyap SR, Schauer PR et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity 2011; 19: 2235-2240.
24. Grant WF, Gillingham MB, Batra AK, Fewkes NM, Comstock SM, Takahashi D et al. Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One 2011; 6: e17261.
25. Hansen B. Investigation and treatment of type 2 diabetes in nonhuman primates. In: Joost H-G, Al-Hasani H, Schü rmann A (eds) Animal Models in Diabetes Research vol. 933. Humana Press Inc.: New York, NY, 2012, pp 177-185.
26. McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, Friedman JE et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009; 119: 323-335.
27. Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 2004; 206: 169-180.
28. Merrill AH. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev 2011; 111: 6387-6422.
29. Merrill JAH, Sandhoff K. Chapter 14 Sphingolipids: metabolism and cell signaling. In: Vance, DE and Vance, JE (eds) New Comprehensive Biochemistry vol. 36. Elsevier Inc.: Waltham, MA, 2002, pp 373.
30. Bertea M, Rutti M, Othman A, Marti-Jaun J, Hersberger M, von Eckardstein A et al. Deoxysphingoid bases as plasma markers in Diabetes mellitus. Lipids Health Dis 2010; 9: 84.
31. Sato T, Nihei Y, Nagafuku M, Tagami S, Chin R, Kawamura M et al. Circulating levels of ganglioside GM3 in metabolic syndrome: a pilot study. Obesity Res Clin Practice 2008; 2: 231-238.
32. Shinsuke Y, Susumu S, Masashi H, Yoshinori H, Tetsuya Y, Takahiro Y et al. Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice. Metabolism 2007; 56: 420-429.
33. Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S et al. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA 2007; 104: 13678-13683.
34. Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 2003; 100: 3445-3449.
35. Penno A, Reilly MM, Houlden H, Laura M, Rentsch K, Niederkofler V et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 2010; 285: 11178-11187.
36. Eichler FS, Hornemann T, McCampbell A, Kuljis D, Penno A, Vardeh D et al. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J Neurosci 2009; 29: 14646-14651.
37. Garofalo K, Penno A, Schmidt BP, Lee H-J, Frosch MP, von Eckardstein A et al. Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest 2011; 121: 4735-4745.
38. Othman A, Rü tti M, Ernst D, Saely C, Rein P, Drexel H et al. Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome? Diabetologia 2012; 55: 421-431.
39. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF et al. A branchedchain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311-326.
40. Shimabukuro M, Higa M, Zhou Y-T, Wang M-Y, Newgard CB, Unger RH. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 1998; 273: 32487-32490.
41. Lipina C, Hundal H. Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance. Diabetologia 2011; 54: 1596-1607.
42. Eckardt K, Taube A, Eckel J. Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocr Metab Disord 2011; 19: 19.
43. Watson ML, Coghlan M, Hundal HS. Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells. Biochem J 2009; 417: 791-801.
44. Hajduch E, Turban S, Le Liepvre X, Le Lay S, Lipina C, Dimopoulos N et al. Targeting of PKCB and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Biochem J 2008; 410: 369-379.
45. Stancevic B, Kolesnick R. Ceramide-rich platforms in transmembrane signaling. FEBS Lett 2010; 584: 1728-1740.
46. Zhang Y, Li X, Becker KA, Gulbins E. Ceramide-enriched membrane domains-Structure and function. Biochim Biophys Acta 2009; 1788: 178-183.
47. Li Z, Li Y, Chakraborty M, Fan Y, Bui HH, Peake DA et al. Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels. J Biol Chem 2009; 284: 27010-27019.
48. Glaros EN, Kim WS, Wu BJ, Suarna C, Quinn CM, Rye K-A et al. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitormyriocin is associated with reduced plasma glycosphingolipid concentration. Biochem Pharmacol 2007; 73: 1340-1346.
49. Inokuchi J. Insulin resistance as a membrane microdomain disorder. Biol Pharm Bull 2006; 29: 1532-1537.
50. Tagami S, Inokuchi J-i, Kabayama K, Yoshimura H, Kitamura F, Uemura S et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 2002; 277: 3085-3092.
51. Bejaoui K, Uchida Y, Yasuda S, Ho M, Nishijima M, Brown Jr RH et al. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis. J Clin Invest 2002; 110: 1301-1308.
52. Hornemann T, Wei Y, von Eckardstein A. Is the mammalian serine palmitoyltransferase a high-molecular-mass complex? Biochem J 2007; 405: 157-164.
53. Han S, Lone MA, Schneiter R, Chang A. Orm1 and Orm2 are conserved endoplasmic reticulum membrane proteins regulating lipid homeostasis and protein quality control. Proc Natl Acad Sci USA 2010; 107: 5851-5856.
54. Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life 2010; 62: 347-356.
55. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78: 838-848.
56. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319: 1244-1247.
57. van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J Biochem 2006; 140: 13-21.
58. Pinto SN, Silva LC, Futerman AH, Prieto M. Effect of ceramide structure on membrane biophysical properties: the role of acyl chain length and unsaturation. Biochim Biophys Acta 2011; 1808: 2753-2760.